Flumeglin Injectable Solution

COMPOSITION Flumeglin Injectable Solution is a colourless and clear solution. Each ml contains flunixin meglumine equivalent to 50 mg of flunixin base. INDICATIONS FOR USE Flumeglin Injectable Solution is a non-steroidal anti-inflammatory drug with antipyretic, analgesic and non-narcotic activities. It is mainly used for the alleviation of inflammation and pain associated with colic in horses, for the control of acute inflammation associated with infectious diseases in cattle. Additionally, in cattle, horses and dogs; – In the treatment of pain and inflammation associated with tendon and musculoskeletal disorders, and pain associated with spasms of smooth muscles of internal organs. – It decreases the amount of lactic acid in blood and tissues and inhibits the decrease of blood pressure, increases the venous return of blood to the heart, reduces the damage in vascular endothelial cells. – For the control of acute inflammations associated with colibacillosis, pneumonia and chronic obstructive respiratory diseases, and also as an adjuvant in the treatment of acute bovine pulmonary emphysema (fog fever) and acute mastitis. ADMINISTRATION ROUTES AND AMOUNTS Administer via slow intravenous or intramuscular injection depending on the animal species, as shown in the table, unless recommended otherwise by the veterinarian. Animal species Application route Pharmacological dose Practical dose (daily) Treatment duration Horse Intravenous Intramuscular 1.1 mg/kg bw 1 ml / 45 kg bw 5 days maximum Cattle Intravenous Intramuscular 2.2 mg/kg bw 4.4 ml / 100 kg bw 3 days maximum Dog Intravenous 0.5 – 2.2 mg/kg bw 0.05 – 0.225 ml / 5 kg bw 3 days maximum For the treatment of equine colic, colitis and endotoxic shock in horses, administer intravenously at the dose of 1.1 mg/kg bw/day (1 ml / 45 kg bw/day), and repeat if necessary. WITHDRAWAL PERIOD(S) Animals should not be slaughtered during the treatment and for 21 days following the last treatment. Cow milk should not be used for human consumption during the treatment and for 5 days (10 milkings) following the last treatment. MARKETING PACKAGING 50 ml, 100 ml and 250 ml in amber coloured glass vials inside cardboard boxes.